CryoTherapeutics
Founded 2009 · 25 employees on LinkedIn · 1 known investors
Find your way into CryoTherapeutics
CryoTherapeutics is developing a device-based treatment for vulnerable (high-risk) atherosclerotic plaque in the coronary arteries, a condition associated with coronary artery disease and heart attacks. The company targets a gap in cardiac care where existing options such as stents do not address the underlying plaque pathology.
Investors · 1
In the news
Frequently asked questions
- What does CryoTherapeutics do?
- CryoTherapeutics is developing a device-based treatment for vulnerable (high-risk) atherosclerotic plaque in the coronary arteries, a condition associated with coronary artery disease and heart attacks. The company targets a gap in cardiac care where existing options such as stents do not address the underlying plaque pathology.
- Who are CryoTherapeutics's investors?
- CryoTherapeutics's investors include Creathor Ventures.